CXCR4 and neoplasm: To our knowledge, this is the first report assessing the concentrations of CXCL12 and CXCR4 in the serum of patients with EC in relation to clinicopathological characteristic of tumor as well as diagnostic and prognostic potential of proteins tested in comparison to classical tumor markers and marker of inflammation (CRP).